ClinicalTrials.gg
Sign In

DrugBiological

BI 836858 clinical trials

Also written BI 836858.

studies test it
5
open now
1
in phase 3
1
first study started
2012

Keep track of what changes. Save the BI 836858 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

BI 836858
4

Studies by the year they started

5 studies that test it; most in 2016 (3)

Studies that test BI 836858, by start year
YearStudies
20121
20151
20163

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Leukemia, Myeloid, Acute
3
Myelodysplastic Syndromes
1

Who runs them

Industry 4 · Other 1

Boehringer Ingelheim (3) · Philogen S.p.A. (1) · Beat AML, LLC (1)

Often tested with

Tested in the same studies.

Decitabine (2) · Samalizumab (1) · Daunorubicin (1) · Cytarabine (1) · Azacitidine (1) · Enasidenib (1) · Entospletinib (1) · Pevonedistat (1)

Studies

Open first, then newest update. How each study uses BI 836858 is read from its arms, and is right about nine times in ten.

Testing it · 5